FDA Adverse Event Injury Summary report: N

MITROFLOW AORTIC PERICARDIAL HEART VALVE

MDR report key: 4252358 · Received November 14, 2014

Report

Report Number
3004478276-2014-00062
Event Type
Injury
Date Received
November 14, 2014
Date of Event
May 1, 2014
Report Date
November 14, 2014
Manufacturer
SORIN GROUP CANADA INC.
Product Code
DYE
PMA / PMN Number
P060038/S002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BECAUSE THE DEVICE WAS NOT RETURNED, SORIN GROUP'S INVESTIGATION WAS LIMITED TO A REVIEW OF THE DEVICE HISTORY RECORDS. THE COMPLETE MANUFACTURING AND MATERIAL RECORDS FOR THE SUBJECT VALVE WERE PULLED AND REVIEWED BY QUALITY CONTROL AT SORIN GROUP (B)(4). THE RESULTS CONFIRMED THAT THIS VALVE SATISFIED ALL MATERIAL, VISUAL, AND PERFORMANCE STANDARDS REQUIRED FOR A LXA19 MITROFLOW AORTIC PERICARDIAL HEART VALVE AT THE TIME OF MANUFACTURE AND RELEASE.

Additional Manufacturer Narrative · 1

RESULTS = THE COMPLETE MANUFACTURING AND MATERIAL RECORDS FOR THE SUBJECT VALVE WERE PULLED AND REVIEWED BY QUALITY CONTROL AT SORIN GROUP (B)(4). THE RESULTS CONFIRMED THAT THIS VALVE SATISFIED ALL MATERIAL, VISUAL, AND PERFORMANCE STANDARDS REQUIRED FOR A LXA19 MITROFLOW AORTIC PERICARDIAL HEART VALVE AT THE TIME OF MANUFACTURE AND RELEASE. SORIN IS STILL CONFIRMING FROM THE HOSPITAL IF DEVICE WILL BE AVAILABLE FOR EVALUATION. HISTOPATHOLOGICAL EXAMINATION WILL BE CONDUCTED, IF VALVE IS RETURNED.

Description of Event or Problem · 1

THE MANUFACTURER WAS NOTIFIED ON (B)(6) 2014 THAT MITROFLOW VALVE (LXA SIZE19) WAS EXPLANTED AFTER 3.2 YEARS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
736963 MITROFLOW AORTIC PERICARDIAL HEART VALVE TISSUE, HEART VALVE DYE SORIN GROUP CANADA INC. LXA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention